LDLR Back

low density lipoprotein receptor (familial hypercholesterolemia)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of LDLR
The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.

Community Annotation of LDLR Add / Edit LDLR: Annotations

No community annotations yet for LDLR.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

LDLR is highly significantly mutated in
(none)
LDLR is significantly mutated in
(none)
LDLR is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for LDLR